𝔖 Bobbio Scriptorium
✦   LIBER   ✦

TGF-α and EGFR in head and neck cancer

✍ Scribed by Jennifer R. Grandis; David J. Tweardy

Publisher
John Wiley and Sons
Year
1993
Tongue
English
Weight
340 KB
Volume
53
Category
Article
ISSN
0730-2312

No coin nor oath required. For personal study only.

✦ Synopsis

The upper aerodigestive tract mucosa of patients who develop squamous cell carcinoma of the head and neck (SCCHN) is predisposed to abnormally regulated growth, evidenced by the high incidence of synchronous and metachronous malignancies. We conducted a series of experiments to show that aberrant regulation of the epithelial growth factor, transforming growth factor alpha (TGFa) and its cell surface receptor, the epidermal growth factor receptor (EGFR), contribute to this predisposition. Using molecular biological techniques, we compared the incidence and mechanism of TGF-a and EGFR over-production in fresh tumors and histologically normal mucosal specimens from patients with SCCHN and normal, control patients without cancer. In patients with SCCHN, TGF-a and EGFR mRNA levels were significantly elevated in both tumor and normal mucosal specimens as compared to levels in control mucosa from non-cancer patients. Neither an enhancement of message stability nor an increase in gene copy number alone accounted for the elevation of EGFR mRNA. Increased production of TGF-a and EGFR mRNAs in the histologically "normal" mucosa of patients at risk for a primary or secondary head and neck cancer may serve both as a marker for malignant transformation and as a target for chemoprevention.

📜 SIMILAR VOLUMES

Mechanisms of resistance to EGFR inhibit
Mechanisms of resistance to EGFR inhibitors in head and neck cancer
✍ Jonathan B. Cooper; Ezra Eddy Wyssam Cohen 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 209 KB

## Abstract Epidermal growth factor receptor (EGFR), a receptor tyrosine kinase that activates multiple signaling pathways, including phosphatidylinositol‐3‐kinase/v‐AKT murine thymoma viral oncogene homolog protein (Akt), has long been a target of novel therapies. Despite universal EGFR expression

Elevated expression of TGF-β1 in head an
Elevated expression of TGF-β1 in head and neck cancer–associated fibroblasts
✍ Eben Rosenthal; Allison McCrory; Melissa Talbert; Geoff Young; Joanne Murphy-Ull 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 239 KB

## Abstract Head and neck cancers are characterized by a vigorous desmoplastic response, but the contribution of stromal‐derived growth factors to the tumor microenvironment is poorly understood. We evaluated the expression of stromal growth factor expression in head and neck squamous cell carcinom

CEA levels in head and neck cancer
CEA levels in head and neck cancer
✍ Norman A. Silverman; John C. Alexander Jr.; Paul B. Chretien 📂 Article 📅 1976 🏛 John Wiley and Sons 🌐 English ⚖ 497 KB 👁 2 views
Proliferative capacity in head and neck
Proliferative capacity in head and neck cancer
✍ Henk Struikmans; Henk B. Kal; Gert J. Hordijk; Ingeborg van der Tweel 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 90 KB 👁 2 views

## Abstract ## Background Shortening of overall treatment time (accelerated radiotherapy) appears to result in an increase of the efficacy of irradiation. In this study, we compared the proliferative capacity between tumors originating in different sites of the head and neck region. Tumors with a